Siemens Receives FDA 510(k) Clearance for IQ-SPECT Technology

December 12, 2008 – Siemens Healthcare announced that it has received FDA 510(k) clearance for IQ-SPECT technology.

Originally introduced at the 2008 Society of Nuclear Medicine Annual Meeting, June 14-18, in New Orleans, IQ-SPECT is Siemens newest Symbia feature that enables a comprehensive cardiac evaluation, including perfusion, attenuation correction and calcium scoring in just five minutes.

IQ-SPECT technology is achieved with SMARTZOOM collimators that magnify the heart while imaging the rest of the torso under traditional conditions. Combining this cardio-centric orbit acquisition technique with fast, 3D iterative reconstruction enables more confident diagnoses and improved patient comfort, enhancing image quality, speed, productivity and throughput.

IQ-SPECT is 510k-cleared and commercially available on all Symbia S and T systems, and is field upgradeable for any existing systems.

For more information: www.siemens.com/healthcare